Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today the availability of the Safe Life A400 Series N95 Respirator with Antimicrobial Protection. Unlike traditional N95 respirators, the A400 is a comfortable, breathable respirator with the added protection of an active antimicrobial based on iodine, which has a nearly 200-year track record for being effective against a broad spectrum of microorganisms.
As the H1N1 influenza virus continues to spread around the world, the need for N95 respirators for healthcare workers and other occupational users is more critical than ever. Last month, the Centers for Disease Control and Prevention (CDC) reinforced its existing guidelines on respiratory protection by recommending the use of fit-tested, N95 respirators for healthcare personnel who are in close contact with patients with suspected or confirmed 2009 H1N1 influenza. Other global health organizations that have publicly supported N95 usage include the Institute of Medicine and the Ontario Ministry of Health.
According to Richard Jaffe, chairman and CEO of Safe Life, the A400 represents a significant technology advancement that addresses the major challenges healthcare workers and other occupational users have long faced when wearing N95 respirators. "In the past 20 years, little has changed in respirator design, which means healthcare workers and other occupational users have been forced to choose between the comfort and breathability of a surgical mask and the filtration power of an N95 respirator," he said. "Now, with the A400, which looks and feels like a surgical mask yet has the full protection of a respirator, workers no longer have to make compromises when it comes to comfort, safety and patient care."